BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18039575)

  • 1. Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
    Xiao Y; Araldi GL; Zhao Z; Reddy A; Karra S; Brugger N; Fischer D; Palmer E; Bao B; McKenna SD
    Bioorg Med Chem Lett; 2008 Jan; 18(2):821-4. PubMed ID: 18039575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agents.
    Elworthy TR; Brill ER; Chiou SS; Chu F; Harris JR; Hendricks RT; Huang J; Kim W; Lach LK; Mirzadegan T; Yee C; Walker KA
    J Med Chem; 2004 Dec; 47(25):6124-7. PubMed ID: 15566283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
    Zhao Z; Araldi GL; Xiao Y; Reddy AP; Liao Y; Karra S; Brugger N; Fischer D; Palmer E
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6572-5. PubMed ID: 17931866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
    Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactams as prostanoid receptor ligands. Part 4: 2-Piperidones as selective EP4 receptor agonists.
    Elworthy TR; Brill ER; Caires CC; Kim W; Lach LK; Tracy JL; Chiou SS
    Bioorg Med Chem Lett; 2005 May; 15(10):2523-6. PubMed ID: 15863309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
    Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostanoid EP agonists on mouse intraocular pressure.
    Saeki T; Ota T; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.
    Elworthy TR; Kertesz DJ; Kim W; Roepel MG; Quattrocchio-Setti L; Smith DB; Tracy JL; Chow A; Li F; Brill ER; Lach LK; McGee D; Yang DS; Chiou SS
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1655-9. PubMed ID: 15026044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on improvement of blood flow in the chronically compressed cauda equina: comparison between a selective prostaglandin E receptor (EP4) agonist and a prostaglandin E1 derivate.
    Sekiguchi M; Konno S; Kikuchi S
    Spine (Phila Pa 1976); 2006 Apr; 31(8):869-72. PubMed ID: 16622373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma.
    Hori R; Nakagawa T; Sugimoto Y; Sakamoto T; Yamamoto N; Hamaguchi K; Ito J
    Neuroscience; 2009 Jun; 160(4):813-9. PubMed ID: 19303430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo.
    Nomi T; Sho M; Akahori T; Kanehiro H; Nakajima Y
    Transplant Proc; 2006 Dec; 38(10):3209-10. PubMed ID: 17175225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
    Cameron KO; Lefker BA; Ke HZ; Li M; Zawistoski MP; Tjoa CM; Wright AS; DeNinno SL; Paralkar VM; Owen TA; Yu L; Thompson DD
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2075-8. PubMed ID: 19250823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats.
    Cameron KO; Lefker BA; Chu-Moyer MY; Crawford DT; Jardine PD; DeNinno SL; Gilbert S; Grasser WA; Ke H; Lu B; Owen TA; Paralkar VM; Qi H; Scott DO; Thompson DD; Tjoa CM; Zawistoski MP
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1799-802. PubMed ID: 16442794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.
    Kambe T; Maruyama T; Nakano M; Nakai Y; Yoshida T; Matsunaga N; Oida H; Konaka A; Maruyama T; Nakai H; Toda M
    Bioorg Med Chem Lett; 2012 Jan; 22(1):396-401. PubMed ID: 22119471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
    Jones RL; Chan KM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.
    Terry KK; Lebel WS; Riccardi KA; Grasser WA; Thompson DD; Paralkar VM
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):3-10. PubMed ID: 18036799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel modified γ-lactam prostanoids as EP4 subtype-selective agonists.
    Kambe T; Maruyama T; Nagase T; Ogawa S; Minamoto C; Sakata K; Maruyama T; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jan; 20(2):702-13. PubMed ID: 22204740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of highly substituted gamma-lactam follicle stimulating hormone receptor agonists.
    Pelletier JC; Rogers J; Wrobel J; Perez MC; Shen ES
    Bioorg Med Chem; 2005 Nov; 13(21):5986-95. PubMed ID: 16099664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
    Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
    Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.